Psychiatry & Neurology, Clinical Neurophysiology · Stanford, CA
NPI
1972779411
Since 2008
Specialty
Psychiatry & Neurology, Clinical Neurophysiology
Code 2084N0600X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
300 Pasteur Dr
Stanford, CA, 94305
Phone (650) 723-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$60K
675 services
Medicare patients, 2024
395
Average age 70
Drug cost, 2024
$845K
1,111 prescriptions
Company payments, 2025
$22K
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mitchell G Miglis was code 99214 (office e&m - established), 183 times for 151 patients. In total Mitchell G Miglis billed 675 services in 21 codes, and Medicare paid $60K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 183 | 151 | $111.90 | $20K |
| 95924 Electrical Nerve Conductivity | Facility | 70 | 70 | $74.58 | $5,221 |
| 95923 Electrical Nerve Conductivity | Facility | 64 | 64 | $38.62 | $2,472 |
| 95810 Sleep Study | Office | 43 | 42 | $104.90 | $4,511 |
| 99213 Office E&M - Established | Office | 41 | 41 | $79.73 | $3,269 |
| 99215 Office E&M - Established | Office | 35 | 29 | $149.03 | $5,216 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 31 | 29 | $14.94 | $463 |
| 99205 Office E&M - New | Office | 29 | 29 | $177.98 | $5,161 |
| 95800 Sleep Study | Office | 24 | 24 | $34.90 | $838 |
| 99203 Office E&M - New | Office | 23 | 23 | $91.61 | $2,107 |
| 99204 Office E&M - New | Office | 20 | 20 | $140.08 | $2,802 |
| 99215 Office E&M - Established | Facility | 20 | 15 | $130.50 | $2,610 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 14 | 13 | $14.98 | $210 |
| 95808 Sleep Study | Office | 14 | 14 | $68.37 | $957 |
By year: 2022 $48K for 584 services; 2023 $49K for 614 services; 2024 $60K for 675 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mitchell G Miglis prescribed most often to Medicare patients was Gabapentin, with 114 prescriptions and refills. In total Mitchell G Miglis wrote 1,111 Medicare prescriptions that cost $845K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 114 | 170 | 25 | $1,846 |
| Droxidopa Generic | 83 | 87 | 14 | $169K |
| Midodrine Hcl Generic | 80 | 147 | 20 | $7,655 |
| Modafinil Generic | 70 | 85 | 14 | $2,845 |
| Clonazepam Generic | 61 | 88 | 13 | $452 |
| Pyridostigmine Bromide Generic | 45 | 94 | 14 | $2,742 |
| Fludrocortisone Acetate Generic | 39 | 89 | 11 | $977 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 36 | 71 | Under 11 | $576 |
| Belsomra Suvorexant | 35 | 43 | Under 11 | $18K |
| Carbamazepine Generic | 26 | 26 | Under 11 | $802 |
| Propranolol Hcl Generic | 25 | 28 | Under 11 | $287 |
| Methadone Hcl Generic | 25 | 25 | Under 11 | $353 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 23 | 41 | Under 11 | $1,475 |
| Atomoxetine Hcl Generic | 23 | 23 | Under 11 | $1,218 |
| Xywav Sodium,calcium,mag,pot Oxybate | 22 | 22 | Under 11 | $264K |
Brand drugs: 134 claims; generic drugs: 977 claims; opioid claims: 63.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mitchell G Miglis $22K ($22K in general payments such as food, travel and fees) from 5 companies. The largest payer was Jazz Pharmaceuticals Inc. with $19K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.